Pfizer Inc.

NYSE:PFE   3:59:59 PM EDT
44.12
+0.36 (+0.82%)
Products, Strategic Combinations

Cytoreason Announces Expanded Collaboration Deal With Pfizer To Deliver Ai For Drug Discovery And Development

Published: 09/20/2022 14:13 GMT
Pfizer Inc. (PFE) - Cytoreason Announces Expanded Collaboration Deal With Pfizer to Deliver Ai for Drug Discovery and Development.
Cytoreason - Under the Terms of the Agreement, Pfizer Will Make a $20m Equity Investment.
Cytoreason - Pfizer Will Have Options to License Co’s Platform & Disease Models, Fund Supplementary Project Support.
Cytoreason - Deal With Pfizer Potentially Worth Up to $110m Over the Next Five Years.
Cytoreason-new Research Agreement,investment to Support Development of Additional Disease Models Spanning Across a Number of Therapeutic Areas.